Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in GBA1 isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism
Chen, C.; Ma, C.; Sam, R.; Lichtenberg, J.; Chen, T.; Hao, Y.; Li, Z.; Kowal, I.; Andersh, K.; Qi, Y. A.; Perez, G.; Hertz, E.; Li, Y.; Williams, D.; Henderson, M. J.; Park, M.; Jiang, X.; Jerez, P. A.; Blauwendraat, C.; Sidransky, E.; Chen, Y.
Show abstract
Variants in GBA1 are common genetic risk factors for several synucleinopathies. The increased risk has been attributed to the toxic effects of misfolded glucocerebrosidase (GCase) (gain-of-function), and the accumulation of lipid substrates due to reduced enzyme activity (loss-of-function). To delineate GBA1 pathogenicity, an iPSC line was generated from a patient with both type 1 Gaucher disease (GBA1: N370S/N370S; p.N409S/p.N409S) and Parkinson disease (PD). From this line, we created a reverted wild-type (WT) line and a GBA1 knockout (KO) line to eliminate misfolded GCase and intensify lipid accumulation. N370S/N370S and KO dopaminergic neurons (DANs) exhibited decreasing GCase levels and progressive accumulation of lipid substrates compared to WT DANs. Notably, the expression of GPNMB, whose levels correlate with PD risk, was upregulated by the mild lipid accumulation in N370S/N370S DANs but disrupted in KO DANs. These findings refine the loss-of-function mechanism by associating PD risk levels of GPNMB with lipid levels specific to GBA1 risk variants.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia 97%
- Mapping PTBP splicing in human brain identifies targets for therapeutic splice switching including SYNGAP1 96%
- Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia 96%
Similar papers in this journal
- SNCA triplication disrupts proteostasis and extracellular architecture prior to neurodegeneration in human midbrain organoids 96%
- Early striatal hyperexcitability in an in vitro human striatal microcircuit model carrying the Parkinson's GBA-N370S mutation 96%
- Protein aggregation and calcium dysregulation are the earliest hallmarks of synucleinopathy in human midbrain dopaminergic neurons 95%
Similar papers in this journal
- GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton 97%
- LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model 96%
- Mitochondrial dysfunction drives a neuronal exhaustion phenotype in methylmalonic aciduria 96%
Similar papers in this journal
- Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons 96%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 95%
- LRRK2 Kinase Activity Regulates Parkinson's Disease-Relevant Lipids at the Lysosome 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.